请选择 进入手机版 | 继续访问电脑版
Home News Content

Baishi Meishi Guibao's US stock rose more than 5% before trading

凉亭之中净
1140 0 0

On September 27th, the US stock market of Bristol Myers Squibb rose more than 5% before trading, as US regulatory authorities approved its Cobenfy for the treatment of schizophrenia, the first drug approved for the treatment of schizophrenia in decades.
Logomoney.com is an information publishing platform that only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

凉亭之中净
  • Follower

    0

  • Follow

    0

  • Article

    1